Bevacizumab suppresses choroidal neovascularization secondary to pathologic myopia: A pilot study

被引：0
|
作者：
Nguyen, QD
Shah, SM
Tatlipinar, S
Do, DV
Van Anden, E
Campochiaro, PA
机构：
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1379
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab-A Randomized Controlled Trial
    Gharbiya, Magda
    Giustolisi, Rosalia
    Allievi, Francesca
    Fantozzi, Nicoletta
    Mazzeo, Luigi
    Scavella, Vittorio
    Gabrieli, Corrado Balacco
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (03) : 458 - 464
  • [32] Comparison of Intravitreal Bevacizumab versus Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia-6 Month Results
    Fonseca, S.
    Carneiro, A.
    Mendonca, L.
    Falcao, M.
    Branclao, E.
    Falcao-Reis, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [33] Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia -: Long-term study
    Pece, Alfredo
    Isola, Vincenzo
    Vadala, Maria
    Matranga, Domenica
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (07): : 746 - 751
  • [34] Intravitreal bevacizumab for choroidal neovascularization due to pathological myopia
    Dithmar, S.
    Schaal, K. B.
    Hoeh, A. E.
    Schmidt, S.
    Schuett, F.
    OPHTHALMOLOGE, 2009, 106 (06): : 527 - 530
  • [35] Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia
    Hashemi, Saba
    Faramarzi, Mohammad Ali
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (12) : 1837 - 1848
  • [36] Lacquer crack formation and choroidal neovascularization in pathologic myopia
    Ikuno, Yasushi
    Sayanagi, Kaori
    Soga, Kaori
    Sawa, Miki
    Gomi, Fumi
    Tsujikawa, Motokazu
    Tano, Yasuo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (08): : 1124 - 1131
  • [37] Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia
    Ozkiris, Abdullah
    Tuzcu, Esra Ahan
    Erkilic, Kuddusi
    Ilhan, Ozgur
    Oner, Ayse
    Yarbag, Abdulhekim
    Pangal, Emine
    ERCIYES MEDICAL JOURNAL, 2008, 30 (04) : 238 - 241
  • [38] Ocular Risk Factors for Choroidal Neovascularization in Pathologic Myopia
    Ikuno, Yasushi
    Jo, Yukari
    Hamasaki, Toshimitsu
    Tano, Yasuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (07) : 3721 - 3725
  • [39] Nine-Year Outcome of Ranibizumab Monotherapy for Choroidal Neovascularization Secondary to Pathologic Myopia
    Pastore, Marco R.
    Capuano, Vittorio
    Bruyere, Elsa
    Miere, Alexandra
    Corbelli, Eleonora
    Querques, Lea
    Tognetto, Daniele
    Bandello, Francesco
    Querques, Giuseppe
    Souied, Eric H.
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 133 - 142
  • [40] Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
    Mones, J. M.
    Amselem, L.
    Serrano, A.
    Garcia, M.
    Hijano, M.
    EYE, 2009, 23 (06) : 1276 - 1280
12345